Insider Selling: Solazyme Director Sells 12,000 Shares of Stock (SZYM)
Solazyme (NASDAQ:SZYM) Director Jerry Fiddler sold 12,000 shares of Solazyme stock in a transaction that occurred on Thursday, June 26th. The stock was sold at an average price of $11.77, for a total value of $141,240.00. Following the completion of the sale, the director now directly owns 47,925 shares of the company’s stock, valued at approximately $564,077. The transaction was disclosed in a filing with the SEC, which is available at this link.
A number of research firms have recently commented on SZYM. Analysts at Morgan Stanley reiterated an “overweight” rating on shares of Solazyme in a research note on Friday, May 30th. They now have a $15.00 price target on the stock. Separately, analysts at Credit Suisse cut their price target on shares of Solazyme from $12.00 to $11.00 in a research note on Wednesday, April 2nd. Finally, analysts at Cowen and Company raised their price target on shares of Solazyme from $17.00 to $18.00 in a research note on Tuesday, April 1st. One equities research analyst has rated the stock with a hold rating and one has given a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $15.00.
Solazyme (NASDAQ:SZYM) traded up 1.20% on Thursday, hitting $11.79. The stock had a trading volume of 686,016 shares. Solazyme has a one year low of $8.00 and a one year high of $15.00. The stock’s 50-day moving average is $10.27 and its 200-day moving average is $10.99. The company’s market cap is $895.7 million.
Solazyme (NASDAQ:SZYM) last released its earnings data on Monday, May 5th. The company reported ($0.44) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.33) by $0.11. The company had revenue of $12.40 million for the quarter, compared to the consensus estimate of $14.63 million. During the same quarter in the prior year, the company posted ($0.43) earnings per share. The company’s quarterly revenue was up 85.1% on a year-over-year basis. On average, analysts predict that Solazyme will post $-1.56 earnings per share for the current fiscal year.
Solazyme, Inc operates as a renewable oil production company. The Company fuels include microbial-derived jet fuels, bio-diesels, and renewable diesels.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.